Mark Neumann

Mark Neumann serves as Executive Vice President, Chief Commercial Officer at Intra-Cellular Therapies. Intra-Cellular Therapies operates in the pharmaceuticals sector with approximately 960.0 employees. The company is headquartered in New York, New York. Intra-Cellular Therapies generates annual revenue of 680500000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Outlook Microsoft Office 365 CloudFlare Hosting Sendgrid Google Font API Mobile Friendly Akamai RUM New Relic Google Analytics Google Tag Manager WordPress.org Gravity Forms Bootstrap Framework Remote AI

neuropsychiatric & neurodegenerative diseases biopharmaceuticals central nervous system disorders schizophrenia research & development drug product development bipolar disorder major depressive disorder parkinsons disease biotechnology life sciences biotechnology: pharmaceutical preparations health care pharmaceutical manufacturing intracellular therapies lumateperone pde inhibitor drug discovery alzheimer's disease parkinson's disease neuropsychiatric disorders neurodevelopmental disorders psychiatric medications drug development fda approval clinical trials mental health innovative treatments cns disorders cognitive impairment behavioral disorders drug pipeline biopharmaceutical clinical research psychiatry patient support drug efficacy safety profiles neuropharmacology metabolic pathways clinical efficacy biotech company medical innovation biomedical research drug interaction therapeutic agents antidepressants antipsychotics opioid use disorder pain management therapies phosphodiesterase inhibitors drug formulation pediatric indications emerging therapies investigational drugs clinical development healthcare solutions patient outcomes mental wellness chronic conditions neurological disorders caplyta bipolar depression intracellular approach caregiver support healthcare providers psychiatric conditions anxiety disorder pain management mood disorders investigational compounds fda-approved commercial strategy neuroscience portfolio patient care healthcare market pharmaceutical industry competitive landscape small molecule drugs transformative therapies unmet medical needs patient demographics insurance coverage caregiver burden collaboration scientific integrity market access health wellness & fitness pharmaceuticals medical hospital & health care

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

How can I contact Mark Neumann?

Mark Neumann's verified email address is available on MessageCEO. They currently work at Intra-Cellular Therapies. Pro subscribers can access direct email addresses for over 200,000 executives.

What company does Mark Neumann lead?

Mark Neumann is Executive Vice President, Chief Commercial Officer at Intra-Cellular Therapies, a company in the pharmaceuticals sector with 960.0 employees. The company is based in New York, New York.

What industry is Mark Neumann in?

Mark Neumann works in the pharmaceuticals industry as Executive Vice President, Chief Commercial Officer at Intra-Cellular Therapies. MessageCEO provides verified contact information for executives across all major industries.

Is Mark Neumann's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Mark Neumann's profile is kept up-to-date with the latest available information.

Last updated: April 7, 2026